0000899243-20-032507.txt : 20201202
0000899243-20-032507.hdr.sgml : 20201202
20201202161712
ACCESSION NUMBER: 0000899243-20-032507
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201201
FILED AS OF DATE: 20201202
DATE AS OF CHANGE: 20201202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENDERSON MICHAEL THOMAS
CENTRAL INDEX KEY: 0001779990
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 201363971
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-01
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001779990
HENDERSON MICHAEL THOMAS
C/O BRIDGEBIO PHARMA, INC.
421 KIPLING STREET
PALO ALTO
CA
94301
0
1
0
0
Chief Business Officer
Common Stock
2020-12-01
4
M
0
10000
1.05
A
284211
D
Common Stock
2020-12-01
4
S
0
3028
51.1214
D
281183
D
Common Stock
2020-12-01
4
S
0
6972
51.6937
D
274211
D
Stock Option (Right to Buy)
1.05
2020-12-01
4
M
0
10000
0.00
D
2020-05-19
2029-09-24
Common Stock
10000
8282
D
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 18, 2020.
Represents the weighted average sale price of the shares sold from $50.41 to $51.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.
Represents the weighted average sale price of the shares sold from $51.41 to $52.36 per share.
/s/ Tara Condon, Attorney-in-Fact
2020-12-02